This monograph, though no new material for the study of cervical cancer is presented, is nonetheless of very considerable interest. In order that the future mass screening by cytology, of all French women over 16 years of age, might be placed on as national a basis as possible, given the often confused, and at times, contradictory nature of much of the literature on the subject, the Institute has analysed and synthesized a vast amount of this literature. The monograph is a most useful contribution, for this alone.
It is emphasized that a clear " mathematical " pattern of the natural history of cervical cancer must be established if screening is to be logically based, implying a knowledge of a number of biological and epidemiological parameters. This information is widely scattered throughout the literature-ideas on dysplasia, carcinoma in situ and invasive carcinoma, and the suggested links between them, the varied treatment plans, are all discussed, and quantitative data are given from all the major screening programmes, from 1949 to 1970. This naturally leads to a general discussion on the problems of mass screening, and especially of their evaluation.
The authors then proceed to define their own problem-size and age of population to be tested, the means to do so, response rates, and the problem of the investigation and surveillance of the positive tests. (1) metabolism of carcinogens, (2) carcinogenesis in vitro and (3) mutagenesis. All papers are presented by authorities in their particular fields. Most of the authors have discussed their own work although there are one or two review papers. The first section, on metabolism, sets out clearly the problems of attempting to extrapolate in vitro animal data to man. Mention is made of sex, species and genetic differences as well as the fine balance between activation and detoxification pathways. These can alter the metabolic pattern of particular chemicals and so contribute to determining carcinogenic sensitivity or resistance. The importance of other factors such as hormonal or immunological status were not included in this Workshop which I feel is a serious omission given the theme of the meeting.
The two papers on cell transformation are in sharp contrast to each other, one discussing transformation in fibroblasts and the other in liver epithelial cells. Clearly it will be some time before the latter cells can be used routinely to screen for carcinogenic substances, since no assay for malignant transformation is yet available.
In the last section dealing with metagenesis various assays are discussed using mammalian cells, micro-organisms and whole animals. No single procedure appears to be adequate at present as a screen for possible carcinogenic substances although several
